LKT Labs

Biochemicals for Life Science Research

AZD-5363

AZD-5363

Product ID A9601
Cas No. 1143532-39-1
Purity ≥99%, ≥99%ee
Product Unit SizeCostQuantityStock
1 mg $63.90 In stock
5 mg $110.30 In stock
25 mg $303.20 In stock
Bulk Quote

Quicklinks

Description

AZD-5363 is an oral pan-AKT inhibitor that causes hyperphosphorylation of AKT, locking it in a catalytically inactive state, unable to phosphorylate downstream signaling substrates such as PRAS40 and GSK-β. This compound displays anticancer chemotherapeutic activity, inhibiting proliferation and inducing tumor regression in in vitro and in vivo models of HER2+ breast cancer and prostate cancer. AZD-5363 may also exhibit inhibitory activity against Rho-associated protein kinase (ROCK), p70S6K, PKA, MKK1, MSK1, MSK2, PKC, PKG, PRKX, and RSK2/3.

Product Info

Cas No.

1143532-39-1
Purity

≥99%, ≥99%ee
Formula

C21H25ClN6O2
Formula Wt.

428.92
IUPAC Name

4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)piperidine-4-carboxamide
Synonym

AZD5363
Solubility

In DMSO(86mg/ml), water with 2 eq. of acid, insoulble on ethanol
Appearance

White Crystal Powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

A9601 MSDS PDF
Info Sheet

A9601 Info Sheet PDF
Brochures

PI3K-Akt-mTORC Pathway Booklet

References

Addie M, Ballard P, Buttar D, et al. Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases. J Med Chem. 2013 Mar 14;56(5):2059-73. PMID: 23394218.

Lamoureux F, Thomas C, Crafter C, et al. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363. Clin Cancer Res. 2013 Feb 15;19(4):833-44. PMID: 23258740.

Davies BR, Greenwood H, Dudley P, et al. Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background. Mol Cancer Ther. 2012 Apr;11(4):873-87. PMID: 22294718.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P6232

    PP-1

    Src inhibitor.
    ≥98%
  • T7036

    Triptorelin

    Peptide, GnRH analog; GnRH agonist.
    ≥98%
  • X1752

    Xenin

    Endogenous peptide hormone, neurotensin analog.
    ≥95%
  • S1604

    Secretin Acetate

    Endogenous peptide hormone, involved in feeding be...
    ≥95%
  • T0114

    Taxinin M

    Taxane found in Taxus; DNA polymerase inhibitor, p...
    ≥98%
  • A4578

    Altretamine

    DNA alkylator.
    ≥98%
  • A6269

    Apremilast

    PDE4 inhibitor.
    ≥98%
  • A0823

    N-Acetyl-S-(N′-methylthiocarbamoyl)-L-cysteine

    Cysteine-ITC conjugate, antioxidant; aldehyde dehy...
    ≥98%
  • N5409

    Nocodazole

    Microtubule polymerization inhibitor.
    ≥98%
  • G3556

    Ginsenoside Rg3

    Triterpene saponin found in species of Panax; γ2 ...
    ≥98%
  • M3232

    Methylisoindigotin

    Indirubin derivative.
    ≥98%
  • A0966

    Adrenocorticotropic Hormone (1-16), human

    Endogenous peptide hormone fragment, involved in s...
    ≥95%
  • R2714

    Recombinant HCV-NS5 Antigens

    Recombinant HCV antigen fragment.
    ≥95%
  • C9612

    Cyclosporin C

    Cyclosporin metabolite; weak calmodulin inhibitor.
    ≥98%
  • G3453

    20(S)-Ginsenoside Rh2

    Triterpene saponin found in Panax.
    ≥98%
  • A2244

    Aflatoxicol

    Mycotoxin, metabolite of aflatoxin B1 produced by ...
    ≥98%
  • T7032

    Triamcinolone

    Synthetic steroid; glucocorticoid agonist.
    ≥98%
  • A0922

    Acetyl-L-Carnitine Hydrochloride

    Carnitine derivative, involved in energy homeostas...
    ≥98%
  • O8503

    Ovalbumin Fragment (323-339)

    OVA antigen.
    ≥98%
  • T3100

    Thyrotropin-releasing Hormone

    Endogenous tripeptide, involved in HPA signaling; ...
    ≥95%